feed,title,long_url,short_url
Benzinga,AB Science communicates the results from phase 2B/3 study evaluating masitinib in Alzheimer's disease,https://www.benzinga.com/pressreleases/20/12/g18848920/ab-science-communicates-the-results-from-phase-2b3-study-evaluating-masitinib-in-alzheimers-diseas,https://j.mp/2LMtxPo
